News
4h
TipRanks on MSNDaVita price target lowered to $148 from $164 at Truist
Truist analyst David MacDonald lowered the firm’s price target on DaVita (DVA) to $148 from $164 and keeps a Hold rating on the shares. The firm ...
Akebia Therapeutics reports strong Q2 2025 earnings, driven by Vafseo’s 55% sales growth. Explore plans for expanded patient access & trial updates.
Learn more about whether Alignment Healthcare, Inc. or DaVita Inc. is a better investment based on AAII's A+ Investor grades, ...
Learn more about whether Addus HomeCare Corporation or DaVita Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
It's estimated that 6.5 million Americans over the age of 20 have heart failure, and the condition is a l | New startup Linea ...
Q2 2025 Earnings Call Transcript August 5, 2025 DaVita Inc. beats earnings expectations. Reported EPS is $2.95, expectations ...
US healthcare company DaVit has revealed it suffered a ransomware attack and a data breach earlier this year which saw ...
DaVita Inc., one of the largest kidney dialysis providers in the world, told regulators that an April cyberattack has cost ...
The stock's fall snapped a two-day winning streak.
DaVita fell victim to a cyberattack back in March of this year during which time hackers gained unauthorized access to its ...
DaVita has notified over 1 million individuals that their personal and health information was stolen in a ransomware attack.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results